Palvella Therapeutics, Inc. (PVLA)
NASDAQ: PVLA · Real-Time Price · USD
74.85
+4.13 (5.84%)
At close: Oct 8, 2025, 4:00 PM EDT
75.01
+0.16 (0.21%)
After-hours: Oct 8, 2025, 7:59 PM EDT

Palvella Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022
Period Ending
Oct '25 Dec '24 Dec '23 Dec '22
828135--
Enterprise Value
772215--
Last Close Price
74.8512.00--
PB Ratio
17.332.15--
P/TBV Ratio
17.332.15--
Debt / Equity Ratio
0.300.19-2.08-1.40
Quick Ratio
7.537.143.112.78
Current Ratio
7.677.333.202.86
Return on Equity (ROE)
-151.15%-59.37%--
Return on Assets (ROA)
-37.25%-18.39%-61.63%-
Return on Capital (ROIC)
-46.16%-22.38%-110.58%-
Earnings Yield
-3.38%-12.95%--
Buyback Yield / Dilution
-19.89%-24.08%68.63%-
Updated Aug 14, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q